Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at ∂ opioid receptors

[1]  J. Willer,et al.  Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAGO in the rat. , 1994, The Journal of pharmacology and experimental therapeutics.

[2]  M. Hamon,et al.  Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo , 1993, Brain Research.

[3]  M. Hamon,et al.  KAPPA-/MU-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord , 1992, Neuroscience.

[4]  T. Yaksh,et al.  Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB). , 1992, The Journal of pharmacology and experimental therapeutics.

[5]  M. Hamon,et al.  Feedback inhibition of met‐enkephalin release from the rat spinal cord in vivo , 1992, Synapse.

[6]  M. Hamon,et al.  к-Opioid receptor stimulation abolishes μ- but not δ-mediated inhibitory control of spinal Met-enkephalin release , 1992, Neuroscience Letters.

[7]  B. de Costa,et al.  Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat. , 1991, The Journal of pharmacology and experimental therapeutics.

[8]  K. Omote,et al.  δ receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats , 1991, Brain Research.

[9]  M. Hamon,et al.  Opioid control of the release of Met-enkephalin-like material from the rat spinal cord , 1991, Brain Research.

[10]  M. Hamon,et al.  Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation , 1991, Neuroscience Letters.

[11]  J. Fujimoto,et al.  Spinal dynorphin A (1–17): Possible mediator of antianalgesic action , 1990, Neuropharmacology.

[12]  J. Besson,et al.  Pre- and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord , 1990, Brain Research.

[13]  D. Zimmerman,et al.  Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. , 1990, Journal of medicinal chemistry.

[14]  M. Hamon,et al.  Intrathecal porcine calcitonin enhances the release of [Met5]enkephalin-like material from the rat spinal cord. , 1989, European journal of pharmacology.

[15]  G. Young,et al.  Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats , 1988, Neuropharmacology.

[16]  B. Carter,et al.  Selectivity of ligand binding to opioid receptors in brain membranes from the rat, monkey and guinea pig. , 1988, European journal of pharmacology.

[17]  P. Portoghese,et al.  Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist , 1988 .

[18]  P. Portoghese,et al.  Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice. , 1987, The Journal of pharmacology and experimental therapeutics.

[19]  A. Herz,et al.  Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats. , 1987, European journal of pharmacology.

[20]  A. Lipkowski,et al.  Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. , 1987, Life sciences.

[21]  M. Millan.  Multiple opioid systems and pain , 1986, Pain.

[22]  F. Artaud,et al.  Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of methionine-enkephalin-like material from the rat spinal cord. , 1986, The Journal of pharmacology and experimental therapeutics.

[23]  P. Portoghese,et al.  The μ, κ and δ properties of various opioid agonists☆ , 1986 .

[24]  J. Besson,et al.  Spontaneous and evoked release of methionine-enkephalin-like material from the rat spinal cord in vivo , 1985, Brain Research.

[25]  V. Go,et al.  Acute and chronic morphine modifies the in vivo release of methionine enkephalin-like immunoreactivity from the cat spinal cord and brain , 1984, Brain Research.

[26]  H. Loh,et al.  Effect of dynorphin-(1-13) and related peptides on respiratory rate and morphine-induced respiratory rate depression. , 1983, European journal of pharmacology.

[27]  J. Y. Wang,et al.  Studies on the release by somatic stimulation from rat and cat spinal cord of active materials which displace dihydromorphine in an opiate-binding assay , 1983, Brain Research.

[28]  B. Roques,et al.  Deltakephalin, Tyr-D-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta-receptors. , 1983, Biochemical and biophysical research communications.

[29]  D. Ganten,et al.  Evidence against co-storage of enkephalins with noradrenaline in bovine adrenal medullary granules. , 1982, European journal of pharmacology.

[30]  J. Besson,et al.  Increased levels of met-enkephalin-like material in the CSF of anaesthetized cats after tooth pulp stimulation , 1982, Brain Research.

[31]  P. Wood,et al.  Multiple opiate receptors: Differential binding of μ, κ and δ agonists , 1981, Neuropharmacology.

[32]  T. Yaksh,et al.  Factors governing release of methionine enkephalin-like immunoreactivity from mesencephalon and spinal cord of the cat in vivo. , 1981, Journal of neurophysiology.

[33]  H. Loh,et al.  Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia. , 1981, The Journal of pharmacology and experimental therapeutics.

[34]  B. Morgan,et al.  Analogues of β-LPH61–64 posessing selective agonist activity at μ-opiate receptors , 1981 .

[35]  T. Yaksh,et al.  Resting and K+-evoked release of serotonin and norepine- phrine in vivo from the rat and cat spinal cord , 1980, Brain Research.

[36]  M. Hamon,et al.  In vivo and in vitro release of central neurotransmitters in relation to pain and analgesia. , 1988, Progress in brain research.

[37]  N. Lee,et al.  Possible regulatory function of dynorphin and its clinical implications , 1984 .

[38]  R. Lahti,et al.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. , 1983, The Journal of pharmacology and experimental therapeutics.